Search Within

Steven Maron

  1. "2021"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (5)
  3. Correspondence (1)
  4. Miscellaneous (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (20)
  2. Gastrointestinal Oncology Service (20)
  3. Solid Tumor Oncology Division (20)
  4. Hematologic Malignancies, Division of (15)
  5. Department of Pathology and Laboratory Medicine (12)
  6. Surgery (12)

More Groups

People
  1. Yelena Janjigian (16)
  2. Geoffrey Ku (13)
  3. David Ilson (9)
  4. Vivian Strong (9)
  5. Laura Tang (8)
  6. Daniela Molena (7)

More People

Years
  1. 2021 (20)
Publications
  1. Journal of Clinical Oncology (9)
  2. Annals of Oncology (4)
  3. Annals of Surgical Oncology (3)
  4. Clinical Cancer Research (1)
  5. JAMA Network Open (1)
  6. JCO Clinical Cancer Informatics (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. Oxford University Press (4)
  3. Springer (3)
  4. American Association for Cancer Research (1)
  5. American Medical Association (1)
  6. Massachusetts Medical Society (1)

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ASO Visual Abstract: Association of obesity with worse operative and oncologic outcomes among patients undergoing gastric cancer resection
    Miscellaneous

    Nakauchi, M.; Vos, E. L.; Tang, L. H.; Gonen, M.; Janjigian, Y. Y.; Ku, G.; Ilson, D.; Maron, S. B.; Yoon, S. S.; Brennan, M. F.; more...
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Frequency of minimal residual disease as measured by ctDNA in mismatch repair deficient tumors following curative resection
    Meeting Abstract

    Lumish, M. A.; Jayakumaran, G.; Fox, M.; Sabwa, S.; Cercek, A.; Stadler, Z. K.; Ku, G. Y.; Segal, N. H.; Won, E.; Maron, S. B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Imaging HER2-positive metastatic esophagogastric cancer with (89)Zr-trastuzumab PET and (18)F-FDG PET
    Meeting Abstract

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Janjigian, Y. Y.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A nutritional management algorithm in older patients with locally advanced esophageal cancer
    Meeting Abstract

    Moy, R. H.; Sabwa, S.; Maron, S. B.; Shcherba, M.; Apollo, A. J.; Janjigian, Y. Y.; Ku, G. Y.; Tew, W. P.; Ilson, D. H.; Won, E.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinical relevance of clonal hematopoiesis in metastatic gastrointestinal malignancies
    Meeting Abstract

    Diplas, B.; Ptashkin, R.; Cercek, A.; Yaeger, R.; Bolton, K. L.; Chalasani, S. B.; Desai, A. M.; Goldberg, Z.; Gu, P.; Li, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • EGFR inhibition in EGFR-amplified esophagogastric cancer (EGC): Retrospective global experience
    Meeting Abstract

    Maron, S.; Moya, S.; Morano, F.; Emmett, M. J.; Disel, U.; Chalasani, S.; Ku, G.; Kasi, P. M.; Uboha, N.; Kato, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and immune responses in a phase I/II study of personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLC
    Meeting Abstract

    Catenacci, D. V.; Liao, C. Y.; Maron, S.; Solomon, B. J.; Mahipal, A.; Johnson, M. L.; Carbone, D.; Henick, B. S.; Johnson, B.; Roychowdhury, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Association of obesity with worse operative and oncologic outcomes for patients undergoing gastric cancer resection
    Journal Article

    Nakauchi, M.; Vos, E. L.; Tang, L. H.; Gonen, M.; Janjigian, Y. Y.; Ku, G. Y.; Ilson, D. H.; Maron, S. B.; Yoon, S. S.; Brennan, M. F.; more...
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes of neoadjuvant chemotherapy for clinical stages 2 and 3 gastric cancer patients: Analysis of timing and site of recurrence
    Journal Article

    Nakauchi, M.; Vos, E.; Tang, L. H.; Gonen, M.; Janjigian, Y. Y.; Ku, G. Y.; Ilson, D. H.; Maron, S. B.; Yoon, S. S.; Brennan, M. F.; more...
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save